Has there been any recent news about Tamiflu?
On November 13, 2006, Roche Laboratories and the FDA notified healthcare professionals of revisions to Tamiflu’s prescribing information to reflect news reports (mostly from Japan) of self-injury and delirium associated with Tamiflu use. People with the flu (particularly children) may be at risk of self-injury and confusion shortly after taking Tamiflu, and should be monitored closely for signs of unusual behavior. Click here for more information from the FDA.
